Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Every meal doesnt have to be perfect but every meal does require ownership
Product Specifications Product Tirzepatide 30mg Peptide Class Dual GLP-1/GIP Receptor Agonist Appearance Lyophilised, Good Purity 99.82% (Full QC Panel HPLC) Net Peptide Content 31.76 mg per vial Lot Number 005-B-SM COA Number COA-2026-ZNN3K3 Testing Lab ILS Laboratories, San Diego (ISO/IEC 17025 Accredited) Fentanyl Screen Not Detected (Pass) Sterility (PCR) No Growth (Pass) Heavy Metals Arsenic, Cadmium, Chromium, Mercury, Lead All Not Detected (Pass) Storage Lyophilised: -20C
Liang C, Zhang XL, Yang MS, Dong XC
Given the massive growth and IGF-1 activity alterations induced by juvenile malnutrition, this prompted us to examine the effects of semaglutide on growth of malnourished juvenile animals
GLP-1 Receptor Agonist Market Demand, Opportunity, 2026-2034 REPORT DETAILS GLP-1 Receptor Agonist Market Overview The global GLP-1 receptor agonist market size was valued at USD 61.89 billion in 2025
PlexusDx's Precision Peptide Genetic Test evaluates your GLP-1 receptor sensitivity and metabolic pathways, enabling tailored dose selection that minimizes side effects while maximizing weight loss
US$ 25.94
US$ 23.95
US$ 21.56
US$ 20.92
US$ 24.47
